← Leaderboards
Xiaobo Mao
Johns Hopkins University
$12,683,437
Attributed
$17,568,418
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.2M · FY2017–25$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,568,418 · 10
By mechanism
R01$9,757,700 · 5
RF1$6,709,705 · 3
K01$650,700 · 1
R21$450,313 · 1
Top collaborators
- Weiyi Peng2 shared
- Liana Isa Shapiro Rosenthal2 shared
- Pengfei Liu1 shared
- Wenjing Wang1 shared
- Zhang Xuan1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Paul F Worley$57,319,879
- Anna Mae Elizabeth Diehl$33,245,963
- Ulrich Mueller$38,859,987
- Marsha W Wills-Karp$29,249,566
- Robert P Schleimer$28,154,309
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposAlpha SynucleinTransmission ProcessPathogenesisPathologicMediatingInsightBrainReceptorPathologySynucleinopathyLymphocyte ActivationGene ActivationMouse ModelMolecularIn VitroNerve DegenerationParkinson DiseaseNeurodegenerative DisordersNeuronsParkinson&AposS DementiaDisease ProgressionAffect
Grant awards (27)
The cross-talk between a-Synucleinopathies and T cell immunity in ADRD$787,127
R01 · FY2025 · AG · contact PI
α-Synuclein strain properties are associated with diagnosis of and progression to Parkinson's disease with dementia$673,092
R01 · FY2025 · NS · contact PI
Mechanism of Pathologic Tau Fibrils Neuron-to-Neuron Transmission and Neuroinflammation in Alzheimer's Disease$620,343
R01 · FY2025 · AG · contact PI
Heterochronic Blood Exchange Inhibits α?Synucleinopathy through Modulating Plasma Protein's Mediation on Pathological α?Synuclein Spreading$441,940
R01 · FY2025 · AG · contact PI
Novel fibril-selective nanobody-based agents targeting intracellular and extracellular α-synuclein aggregates and prion-like propagation induced dementia$2,280,379
RF1 · FY2024 · NS
The cross-talk between a-Synucleinopathies and T cell immunity in ADRD$834,685
R01 · FY2024 · AG · contact PI
Mechanism of Pathologic Tau Fibrils Neuron-to-Neuron Transmission and Neuroinflammation in Alzheimer's Disease$633,002
R01 · FY2024 · AG · contact PI
Heterochronic Blood Exchange Inhibits α?Synucleinopathy through Modulating Plasma Protein's Mediation on Pathological α?Synuclein Spreading$450,959
R01 · FY2024 · AG · contact PI
Determine the role of atmospheric particulate matter pollutants in contributing to Lewy Body Dementia$2,296,059
RF1 · FY2023 · AG · contact PI
Mechanism of Pathologic Tau Fibrils Neuron-to-Neuron Transmission and Neuroinflammation in Alzheimer's Disease$633,002
R01 · FY2023 · AG · contact PI
Heterochronic Blood Exchange Inhibits α?Synucleinopathy through Modulating Plasma Protein's Mediation on Pathological α?Synuclein Spreading$450,959
R01 · FY2023 · AG · contact PI
Understanding the Mechanism of Pathological alpha-Synuclein Transmission$409,375
R01 · FY2023 · NS · contact PI
α-Synuclein strain properties are associated with diagnosis of and progression to Parkinson's disease with dementia$2,133,267
RF1 · FY2022 · NS · contact PI
Mechanism of Pathologic Tau Fibrils Neuron-to-Neuron Transmission and Neuroinflammation in Alzheimer's Disease$633,002
R01 · FY2022 · AG · contact PI
Heterochronic Blood Exchange Inhibits α?Synucleinopathy through Modulating Plasma Protein's Mediation on Pathological α?Synuclein Spreading$450,959
R01 · FY2022 · AG · contact PI
Chemical Fingerprints of Cognitive Impairment-related alpha-Synuclein Strains using 3D Small Molecule Microarray and Related Therapeutic Application$450,313
R21 · FY2022 · NS · contact PI
Understanding the Mechanism of Pathological alpha-Synuclein Transmission$409,375
R01 · FY2022 · NS · contact PI
Mechanism of Pathologic Tau Fibrils Neuron-to-Neuron Transmission and Neuroinflammation in Alzheimer's Disease$634,859
R01 · FY2021 · AG · contact PI
Heterochronic Blood Exchange Inhibits α?Synucleinopathy through Modulating Plasma Protein's Mediation on Pathological α?Synuclein Spreading$466,896
R01 · FY2021 · AG · contact PI
Understanding the Mechanism of Pathological alpha-Synuclein Transmission$409,375
R01 · FY2021 · NS · contact PI
Influence of Aging on Pathogenic Alpha-Synuclein Strains and Transmission Mechanism$130,140
K01 · FY2021 · AG · contact PI
Understanding the Mechanism of Pathological alpha-Synuclein Transmission$409,375
R01 · FY2020 · NS · contact PI
Influence of Aging on Pathogenic Alpha-Synuclein Strains and Transmission Mechanism$130,140
K01 · FY2020 · AG · contact PI
Understanding the Mechanism of Pathological alpha-Synuclein Transmission$409,375
R01 · FY2019 · NS · contact PI
Influence of Aging on Pathogenic Alpha-Synuclein Strains and Transmission Mechanism$130,140
K01 · FY2019 · AG · contact PI
Influence of Aging on Pathogenic Alpha-Synuclein Strains and Transmission Mechanism$130,140
K01 · FY2018 · AG · contact PI
Influence of Aging on Pathogenic Alpha-Synuclein Strains and Transmission Mechanism$130,140
K01 · FY2017 · AG · contact PI